Regulatory Framework Overview
China's medical device regulatory framework is established by the Medical Device Supervision and Administration Regulations 2021 (MDSAR 2021 — State Council Order No. 739) and administered at three levels of government authority. Understanding this three-tier structure is essential before navigating any specific requirement.
The three-tier authority split — where the level of government responsible for registration or filing depends on the device class — has no equivalent in the FDA, EU MDR, TGA, or HSA frameworks.
The three-tier authority structure
| Device class | Registration/filing authority | Technical review |
|---|---|---|
| Class I | District/county-level NMPA bureau (or municipal in some jurisdictions) | Self-declaration; no independent technical review |
| Class II | Provincial NMPA bureau | Provincial bureau technical review team |
| Class III (domestic) | National NMPA | CMDE (Centre for Medical Device Evaluation) |
| All imported devices (Class I–III) | National NMPA | CMDE (for Class II/III); national NMPA for Class I filing |
Key institutions
NMPA — National Medical Products Administration (国家药品监督管理局)
The national authority responsible for medical device regulation. NMPA issues all Class III registrations and all imported device registrations, promulgates regulations and orders, and oversees national market surveillance.
- Website: www.nmpa.gov.cn
CMDE — Centre for Medical Device Evaluation (国家药品监督管理局医疗器械技术审评中心)
The technical review body under NMPA that evaluates Class III and imported medical device registration dossiers. CMDE issues supplemental information requests (补充资料通知) and technical review opinions. The NMPA then makes the administrative registration decision.
- Website: www.cmde.org.cn
Provincial NMPA bureaux (省级药品监督管理局)
Each of China's 31 provinces, autonomous regions, and municipalities has an NMPA bureau responsible for Class II medical device registrations and GMP supervision of Class II/III manufacturers within its territory.
District/county-level bureaux (市/县级市场监督管理局)
Responsible for Class I medical device filings and market supervision of distributors and users.
Primary legislation
| Instrument | Status |
|---|---|
| MDSAR 2021 (State Council Order No. 739) | Primary regulation — in force from 1 June 2021 |
| Registration & Filing Measures (NMPA Order No. 47) | Implementing measure for devices |
| IVD Registration & Filing Measures (NMPA Order No. 48) | Implementing measure for IVDs |
| Production Supervision Measures (NMPA Order No. 53) | GMP obligations |
| Operation Supervision Measures (NMPA Order No. 54) | Distribution obligations |
See Legislation & Regulations for the full legislative index.
Content on this site is written with AI assistance and is intended as a navigation aid only. Always verify against official NMPA sources before making regulatory decisions. Not affiliated with NMPA or any Chinese Government body. Not legal or regulatory advice.